Roche
RO.SW
#43
Rank
NZ$599.76 B
Marketcap
NZ$753.83
Share price
0.64%
Change (1 day)
36.08%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$36.18

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$36.18. In 2025 the company made an earnings per share (EPS) of NZ$36.18 an increase over its 2024 EPS that were of NZ$20.36.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$36.1877.67%
2024NZ$20.36-32.84%
2023NZ$30.321.95%
2022NZ$29.74-6.29%
2021NZ$31.73-5.53%
2020NZ$33.5916.56%
2019NZ$28.8230.3%
2018NZ$22.1220.22%
2017NZ$18.40-5.81%
2016NZ$19.534.62%
2015NZ$18.67-5.13%
2014NZ$19.68-25.05%
2013NZ$26.2621.73%
2012NZ$21.573.82%
2011NZ$20.778.16%
2010NZ$19.2123.72%
2009NZ$15.52-12.31%
2008NZ$17.70-0.34%
2007NZ$17.7632.13%
2006NZ$13.4442.56%
2005NZ$9.43-22.7%
2004NZ$12.20132.85%
2003NZ$5.24-149.3%
2002NZ-$10.63-209.09%
2001NZ$9.74-57.03%
2000NZ$22.6753.29%
1999NZ$14.7931.24%
1998NZ$11.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.46-57.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.43-65.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.39-82.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.63-29.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.53-87.48%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.66-73.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.30-82.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.88-80.98%๐Ÿ‡ฌ๐Ÿ‡ง UK